Understanding Hepatitis B Carrier diagnosis? Find information on healthcare documentation, medical coding (ICD-10-CM B18.0, Z22.5), clinical guidelines, and chronic HBV management for asymptomatic carriers. Learn about lab tests, HBsAg positivity, antiviral therapy considerations, and the importance of accurate medical records for Hepatitis B virus carriers.
Also known as
Chronic viral hepatitis B
Covers chronic hepatitis B infection, including carrier status.
Carrier of infectious disease
Indicates a person carries an infectious agent, including hepatitis B.
Unspecified viral hepatitis
Used when the specific viral hepatitis type is not documented as B.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the patient currently experiencing acute Hepatitis B?
Yes
Is there chronic Hepatitis B?
No
Is Hepatitis B chronic?
When to use each related code
Description |
---|
Hepatitis B Carrier |
Chronic Hepatitis B |
Inactive Hepatitis B |
Coding Hepatitis B carrier without specifying active vs inactive status can lead to inaccurate risk assessment and reimbursement.
Miscoding acute or chronic Hepatitis B infection as carrier status can impact quality reporting and patient management.
Lack of proper documentation of Hepatitis B vaccination status can lead to incorrect carrier coding and unnecessary testing.
Patient presents for follow-up regarding chronic hepatitis B infection, diagnosed as a hepatitis B carrier. The patient is asymptomatic and denies fatigue, abdominal pain, jaundice, or dark urine. Physical examination reveals no hepatosplenomegaly or other significant findings. Laboratory results demonstrate positive hepatitis B surface antigen (HBsAg), positive hepatitis B e antibody (anti-HBe), and detectable hepatitis B virus (HBV) DNA viral load. Liver function tests, including ALT and AST, are within normal limits. Diagnosis of hepatitis B carrier state confirmed. Patient education provided regarding the importance of regular monitoring, including HBV DNA and liver function tests, to assess disease activity and the potential need for future antiviral therapy. Discussion included transmission precautions, vaccination of household contacts, and avoidance of alcohol and hepatotoxic medications. Patient understands the importance of ongoing surveillance and agrees to adhere to the recommended monitoring schedule. ICD-10 code B18.0, chronic viral hepatitis B without delta-agent, assigned. Follow-up scheduled in six months for repeat laboratory evaluation and clinical assessment. No acute complications or exacerbations noted. Patient tolerating current management plan well.